EDGAR Filing Documents for 0001171843-15-006467

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001171843-15-006467

Filing Date

2015-11-20

Accepted

2015-11-20 16:04:37

Documents

Period of Report

2015-03-04

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	formthree.html	3
1	OWNERSHIP DOCUMENT	formthree.xml	3	2807
2	POWER OF ATTORNEY	exh_24.htm	EX-24	7080
	Complete submission text file	0001171843-15-006467.txt		11237

Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814

Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400

Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MICROMET, INC. 6707 DEMOCRACY BLVD., STE. 505 BETHESDA MD 28017

Business Address

Type: 3 | Act: 34 | File No.: 001-33609 | Film No.: 151246662